Acadia Healthcare Taps Former CEO Debbie Osteen as Interim Leader Amid Market Challenges
Event summary
- Debbie Osteen, former CEO and board member, returns as interim CEO of Acadia Healthcare, replacing Chris Hunter effective immediately.
- Osteen previously led Acadia from 2018 to 2022 and brings extensive behavioral healthcare experience from Universal Health Services.
- Acadia reaffirms 2025 financial guidance: $3.28B–$3.30B revenue, $601M–$611M adjusted EBITDA, and $1.94–$2.04 adjusted EPS.
- Board initiates search for long-term successor while evaluating strategies to enhance shareholder value.
- Osteen's reappointment comes amid macroeconomic headwinds impacting healthcare providers.
The big picture
Acadia's return to Debbie Osteen as CEO underscores the need for steady leadership amid a turbulent healthcare landscape. As the largest standalone behavioral healthcare provider in the U.S., Acadia faces macroeconomic headwinds and regulatory shifts, including the impact of the One Big Beautiful Bill Act (OBBBA). Osteen's deep industry experience and prior success at Acadia position her to steer the company through these challenges while the board evaluates long-term strategic options.
What we're watching
- Leadership Stability
- Whether Osteen's interim role can provide continuity while the board conducts a long-term CEO search.
- Market Adaptation
- How Acadia navigates ongoing macroeconomic challenges and regulatory changes under Osteen's leadership.
- Financial Performance
- The pace at which Acadia can deliver on its reaffirmed 2025 financial guidance amid industry pressures.
Related topics